GB9721961D0 - Novel molecules - Google Patents

Novel molecules

Info

Publication number
GB9721961D0
GB9721961D0 GBGB9721961.2A GB9721961A GB9721961D0 GB 9721961 D0 GB9721961 D0 GB 9721961D0 GB 9721961 A GB9721961 A GB 9721961A GB 9721961 D0 GB9721961 D0 GB 9721961D0
Authority
GB
United Kingdom
Prior art keywords
novel molecules
molecules
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9721961.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GBGB9721961.2A priority Critical patent/GB9721961D0/en
Publication of GB9721961D0 publication Critical patent/GB9721961D0/en
Priority to PCT/EP1998/006497 priority patent/WO1999020755A2/en
Priority to AU13347/99A priority patent/AU1334799A/en
Priority to JP2000517076A priority patent/JP2002508922A/ja
Priority to EP98956844A priority patent/EP1027438A2/en
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB9721961.2A 1997-10-16 1997-10-16 Novel molecules Ceased GB9721961D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GBGB9721961.2A GB9721961D0 (en) 1997-10-16 1997-10-16 Novel molecules
PCT/EP1998/006497 WO1999020755A2 (en) 1997-10-16 1998-10-14 Novel cytokine receptors
AU13347/99A AU1334799A (en) 1997-10-16 1998-10-14 Novel cytokine receptors
JP2000517076A JP2002508922A (ja) 1997-10-16 1998-10-14 新規サイトカインレセプター
EP98956844A EP1027438A2 (en) 1997-10-16 1998-10-14 Novel cytokine receptors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9721961.2A GB9721961D0 (en) 1997-10-16 1997-10-16 Novel molecules

Publications (1)

Publication Number Publication Date
GB9721961D0 true GB9721961D0 (en) 1997-12-17

Family

ID=10820679

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9721961.2A Ceased GB9721961D0 (en) 1997-10-16 1997-10-16 Novel molecules

Country Status (5)

Country Link
EP (1) EP1027438A2 (ja)
JP (1) JP2002508922A (ja)
AU (1) AU1334799A (ja)
GB (1) GB9721961D0 (ja)
WO (1) WO1999020755A2 (ja)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999035264A1 (en) * 1998-01-09 1999-07-15 Immunex Corporation H14 dna and polypeptides
US6060276A (en) * 1998-01-22 2000-05-09 Regeneron Pharmaceuticals, Inc. Nucleic acids encoding novel orphan cytokine receptors
EP1068322A1 (en) * 1998-04-10 2001-01-17 Genetics Institute, LLC U4, a member of the hematopoietin receptor superfamily
US6800460B1 (en) 1999-03-11 2004-10-05 Schering Corporation Mammalian cytokine complexes
DE60041393D1 (de) * 1999-03-11 2009-03-05 Schering Corp Cytokine aus säugetieren, verwandte reagenzien und verfahren
EP1950299A1 (en) 1999-06-01 2008-07-30 Schering Corporation Mammalian receptor proteins; related reagents and methods
JP6692826B2 (ja) 2015-03-10 2020-05-13 アドゥロ バイオテック,インク. 「インターフェロン遺伝子刺激因子」依存性シグナル伝達の活性化のための組成物及び方法
GB201522186D0 (en) 2015-12-16 2016-01-27 Singapore Health Services Pte Ltd And Nat University Of Singapore The Treatment of fibrosis
GB201621439D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore IL-11Ra Antibodies
KR20190096390A (ko) 2016-12-16 2019-08-19 싱가포르 헬스 서비시즈 피티이 엘티디 Il-11 항체
GB201621431D0 (en) 2016-12-16 2017-02-01 Singapore Health Services Pte Ltd And Nat Univ Of Singapore The Decoy cytokine receptor
CN113677706A (zh) 2019-01-21 2021-11-19 新加坡保健服务私人有限公司 肝毒性的治疗

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN564195A0 (en) * 1995-09-26 1995-10-19 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor and genetic sequences encoding same
CA2238080C (en) * 1995-10-23 2012-03-13 Amrad Operations Pty. Ltd. A novel haemopoietin receptor and genetic sequences encoding same
AUPO224696A0 (en) * 1996-09-11 1996-10-03 Amrad Operations Pty. Limited A novel haemopoietin receptor and genetic sequences encoding same
AU5733898A (en) * 1997-01-16 1998-08-07 Genetics Institute Inc. Member of the hematopoietin receptor superfamily
WO1998049307A1 (en) * 1997-05-01 1998-11-05 Zymogenetics, Inc. Mammalian cytokine-like receptor

Also Published As

Publication number Publication date
WO1999020755A2 (en) 1999-04-29
AU1334799A (en) 1999-05-10
EP1027438A2 (en) 2000-08-16
JP2002508922A (ja) 2002-03-26
WO1999020755A3 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
EP1015578A4 (en) THERAPEUTIC MOLECULES
PL339769A1 (en) Novel combination
HK1026889A1 (en) Novel aryloxy-alkyl-dialkylamines
EP1042459A4 (en) BIFUNCTIONAL MOLECULES
SI1036083T1 (en) Novel 9a-azalides
GB9718366D0 (en) Novel combinations
GB9705787D0 (en) Modified dendroaspins
GB9721961D0 (en) Novel molecules
EP0986389A4 (en) NEW PROCESS
GB9710497D0 (en) Novel molecule
GB9700690D0 (en) Novel process
GB9708280D0 (en) Novel process
ZA985543B (en) Novel methods
PL318601A1 (en) Novel 5-arylidene-4-oxo-2-imidazpglycines
AUPO510197A0 (en) Novel molecules
AUPP042297A0 (en) Novel molecules
ZA9810745B (en) Novel receptor-OPG2
SI0983266T1 (en) novel tetrahydroisoquinolin thiophenecarboximidamides
GB9716916D0 (en) DNA Molecules
GB9701916D0 (en) Novel combinations
ZA985544B (en) Novel methods
GB9712208D0 (en) Novel spite
GB9703310D0 (en) Novel process
GB9702553D0 (en) Novel process
GB9702541D0 (en) Novel process

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)